|
DCP1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.420000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.207200E-01 |
| Normal-vs-Stage2 |
7.152200E-01 |
| Normal-vs-Stage3 |
5.386200E-01 |
| Normal-vs-Stage4 |
6.695700E-02 |
| Stage1-vs-Stage2 |
5.117400E-01 |
| Stage1-vs-Stage3 |
7.139000E-01 |
| Stage1-vs-Stage4 |
3.252400E-01 |
| Stage2-vs-Stage3 |
4.590200E-01 |
| Stage2-vs-Stage4 |
2.008600E-01 |
| Stage3-vs-Stage4 |
5.236800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.710000E-01 |
| Normal-vs-AfricanAmerican |
8.693600E-01 |
| Normal-vs-Asian |
1.995940E-03 |
| Caucasian-vs-AfricanAmerican |
6.142600E-01 |
| Caucasian-vs-Asian |
4.941100E-03 |
| AfricanAmerican-vs-Asian |
4.655900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.189800E-01 |
| Normal-vs-Female |
1.393210E-01 |
| Male-vs-Female |
9.601600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.443600E-01 |
| Normal-vs-Extreme_Weight |
3.702100E-02 |
| Normal-vs-Obese |
5.588800E-01 |
| Normal-vs-Extreme_Obese |
7.164200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.579000E-01 |
| Normal_Weight-vs-Obese |
1.311850E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.977400E-01 |
| Extreme_Weight-vs-Obese |
1.788300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.565600E-01 |
| Obese-vs-Extreme_Obese |
5.322200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.013200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.138000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.476200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.775640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.562800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.058400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.351000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.808200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.306800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.832000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.230200E-01 |
| Normal-VS-Type2 PRCC |
5.191700E-02 |
| Normal-VS-KIRP CIMP |
7.448200E-01 |
| Normal-VS-Unclassified PRCC |
4.118800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.203600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.157400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.622200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.183400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.625600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.074800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.738200E-03 |
| Normal-vs-N1 |
6.466200E-01 |
| Normal-vs-N2 |
2.976200E-01 |
| N0-vs-N1 |
1.377390E-01 |
| N0-vs-N2 |
8.180400E-01 |
| N1-vs-N2 |
6.611800E-01 |
|
|
